Animal models for SARS and MERS coronaviruses

Current Opinion in Virology

Volumn 13, Issue , 2015, Pages 123-129

  Gretebeck, Lisa M ^a   Subbarao, Kanta ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS VACCINE; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; UNCLASSIFIED DRUG;

ARTICLE; EXPERIMENTAL MODEL; FERRET; HAMSTER; HUMAN; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RHESUS MONKEY; SEVERE ACUTE RESPIRATORY SYNDROME; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; CORONAVIRUS INFECTION; DISEASE MODEL; GENETICS; PHYSIOLOGY; SARS CORONAVIRUS; VIROLOGY;

ANIMALS; CORONAVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; HUMANS; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 84937555298     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2015.06.009     Document Type: Review

References (66)

1. P.S. Masters, and S. Perlman Coronaviridae DM Knipe, PM Howley, Field's Virology edn 6th 2013 Wolters Kluwer/Lippincott Williams & Wilkins Health 825 858
2. L.E. Gralinski, and R.S. Baric Molecular pathology of emerging coronavirus infections J Pathol 235 2015 185 195
3. W. Li, M.J. Moore, N. Vasilieva, J. Sui, S.K. Wong, M.A. Berne, M. Somasundaran, J.L. Sullivan, K. Luzuriaga, T.C. Greenough, and et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus Nature 426 2003 450 454
4. S.K. Wong, W. Li, M.J. Moore, H. Choe, and M. Farzan A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2 J Biol Chem 279 2004 3197 3201
5. G. Lu, Y. Hu, Q. Wang, J. Qi, F. Gao, Y. Li, Y. Zhang, W. Zhang, Y. Yuan, J. Bao, and et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26 Nature 500 2013 227 231
6. V.S. Raj, H. Mou, S.L. Smits, D.H. Dekkers, M.A. Muller, R. Dijkman, D. Muth, J.A. Demmers, A. Zaki, R.A. Fouchier, and et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC Nature 495 2013 251 254
7. T.G. Ksiazek, D. Erdman, C.S. Goldsmith, S.R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J.A. Comer, W. Lim, and et al. A novel coronavirus associated with severe acute respiratory syndrome N Engl J Med 348 2003 1953 1966
8. WHO: Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Available from http://www.who.int/csr/sars/country/table2004-04-21/en/.
9. A. Bermingham, M.A. Chand, C.S. Brown, E. Aarons, C. Tong, C. Langrish, K. Hoschler, K. Brown, M. Galiano, R. Myers, and et al. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012 Euro Surveill 17 2012 20290
10. WHO: Middle East respiratory syndrome coronavirus (MERS-CoV) - update May 9, 2014. Available at http://www.who.int/csr/disease/coronavirus-infections/MERS-CoV-Update-09-May-2014.pdf?ua=1
11. A.M. Zaki, S. van Boheemen, T.M. Bestebroer, A.D. Osterhaus, and R.A. Fouchier Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia N Engl J Med 367 2012 1814 1820
12. M. Bolles, D. Deming, K. Long, S. Agnihothram, A. Whitmore, M. Ferris, W. Funkhouser, L. Gralinski, A. Totura, M. Heise, and et al. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge J Virol 85 2011 12201 12215
13. C.M. Booth, L.M. Matukas, G.A. Tomlinson, A.R. Rachlis, D.B. Rose, H.A. Dwosh, S.L. Walmsley, T. Mazzulli, M. Avendano, P. Derkach, and et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area JAMA 289 2003 2801 2809
14. N. Lee, H.D. Wu, A. Chan, P. Cameron, P. Joynt, G.M. Ahuja, A. Yung, M.Y. Leung, C.B. To, K.F. Lui, and et al. A major outbreak of severe acute respiratory syndrome in Hong Kong N Engl J Med 348 2003 1986 1994
15. J.S. Peiris, S.T. Lai, L.L. Poon, Y. Guan, L.Y. Yam, W. Lim, J. Nicholls, W.K. Yee, W.W. Yan, M.T. Cheung, and et al. Coronavirus as a possible cause of severe acute respiratory syndrome Lancet 361 2003 1319 1325
16. S.M. Poutanen, D.E. Low, B. Henry, S. Finkelstein, D. Rose, K. Green, R. Tellier, R. Draker, D. Adachi, M. Ayers, and et al. Identification of severe acute respiratory syndrome in Canada N Engl J Med 348 2003 1995 2005
17. K.W. Tsang, P.L. Ho, G.C. Ooi, W.K. Yee, T. Wang, M. Chan-Yeung, W.K. Lam, W.H. Seto, L.Y. Yam, T.M. Cheung, and et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong N Engl J Med 348 2003 1977 1985
18. A. Assiri, J.A. Al-Tawfiq, A.A. Al-Rabeeah, F.A. Al-Rabiah, S. Al-Hajjar, A. Al-Barrak, H. Flemban, W.N. Al-Nassir, H.H. Balkhy, R.F. Al-Hakeem, and et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study Lancet Infect Dis 13 2013 752 761
19. Y. Ding, H. Wang, H. Shen, Z. Li, J. Geng, H. Han, J. Cai, X. Li, W. Kang, D. Weng, and et al. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China J Pathol 200 2003 282 289
20. T.J. Franks, P.Y. Chong, P. Chui, J.R. Galvin, R.M. Lourens, A.H. Reid, E. Selbs, C.P. McEvoy, C.D. Hayden, J. Fukuoka, and et al. Lung pathology of severe acute respiratory syndrome (SARS): a study of 8 autopsy cases from Singapore Hum Pathol 34 2003 743 748
21. J.M. Nicholls, L.L. Poon, K.C. Lee, W.F. Ng, S.T. Lai, C.Y. Leung, C.M. Chu, P.K. Hui, K.L. Mak, W. Lim, and et al. Lung pathology of fatal severe acute respiratory syndrome Lancet 361 2003 1773 1778
22. J. McAuliffe, L. Vogel, A. Roberts, G. Fahle, S. Fischer, W.J. Shieh, E. Butler, S. Zaki, M. St Claire, B. Murphy, and et al. Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys Virology 330 2004 8 15
23. T. Rowe, G. Gao, R.J. Hogan, R.G. Crystal, T.G. Voss, R.L. Grant, P. Bell, G.P. Kobinger, N.A. Wivel, and J.M. Wilson Macaque model for severe acute respiratory syndrome J Virol 78 2004 11401 11404
24. R.A. Fouchier, T. Kuiken, M. Schutten, G. van Amerongen, G.J. van Doornum, B.G. van den Hoogen, M. Peiris, W. Lim, K. Stohr, and A.D. Osterhaus Aetiology: Koch's postulates fulfilled for SARS virus Nature 423 2003 240
25. T. Kuiken, R.A. Fouchier, M. Schutten, G.F. Rimmelzwaan, G. van Amerongen, D. van Riel, J.D. Laman, T. de Jong, G. van Doornum, W. Lim, and et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome Lancet 362 2003 263 270
26. J.V. Lawler, T.P. Endy, L.E. Hensley, A. Garrison, E.A. Fritz, M. Lesar, R.S. Baric, D.A. Kulesh, D.A. Norwood, L.P. Wasieloski, and et al. Cynomolgus macaque as an animal model for severe acute respiratory syndrome PLoS Med 3 2006 e149
27. T.C. Greenough, A. Carville, J. Coderre, M. Somasundaran, J.L. Sullivan, K. Luzuriaga, and K. Mansfield Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus Am J Pathol 167 2005 455 463
28. E. de Wit, A.L. Rasmussen, D. Falzarano, T. Bushmaker, F. Feldmann, D.L. Brining, E.R. Fischer, C. Martellaro, A. Okumura, J. Chang, and et al. Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques Proc Natl Acad Sci U S A 110 2013 16598 16603
29. Y. Yao, L. Bao, W. Deng, L. Xu, F. Li, Q. Lv, P. Yu, T. Chen, Y. Xu, H. Zhu, and et al. An animal model of MERS produced by infection of rhesus macaques with MERS coronavirus J Infect Dis 209 2014 236 242
30. D. Falzarano, E. de Wit, F. Feldmann, A.L. Rasmussen, A. Okumura, X. Peng, M.J. Thomas, N. van Doremalen, E. Haddock, L. Nagy, and et al. Infection with MERS-CoV causes lethal pneumonia in the common marmoset PLoS Pathog 10 2014 e1004250
31. W.G. Glass, K. Subbarao, B. Murphy, and P.M. Murphy Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice J Immunol 173 2004 4030 4039
32. R.J. Hogan, G. Gao, T. Rowe, P. Bell, D. Flieder, J. Paragas, G.P. Kobinger, N.A. Wivel, R.G. Crystal, J. Boyer, and et al. Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1 J Virol 78 2004 11416 11421
33. K. Subbarao, J. McAuliffe, L. Vogel, G. Fahle, S. Fischer, K. Tatti, M. Packard, W.J. Shieh, S. Zaki, and B. Murphy Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice J Virol 78 2004 3572 3577
34. A. Roberts, C. Paddock, L. Vogel, E. Butler, S. Zaki, and K. Subbarao Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans J Virol 79 2005 5833 5838
35. J. Chen, Y.F. Lau, E.W. Lamirande, C.D. Paddock, J.H. Bartlett, S.R. Zaki, and K. Subbarao Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection J Virol 84 2010 1289 1301
36. T. Baas, A. Roberts, T.H. Teal, L. Vogel, J. Chen, T.M. Tumpey, M.G. Katze, and K. Subbarao Genomic analysis reveals age-dependent innate immune responses to severe acute respiratory syndrome coronavirus J Virol 82 2008 9465 9476
37. M.B. Frieman, J. Chen, T.E. Morrison, A. Whitmore, W. Funkhouser, J.M. Ward, E.W. Lamirande, A. Roberts, M. Heise, K. Subbarao, and et al. SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I II and III interferon receptor independent mechanism PLoS Pathog 6 2010 e1000849
38. P.B. McCray Jr., L. Pewe, C. Wohlford-Lenane, M. Hickey, L. Manzel, L. Shi, J. Netland, H.P. Jia, C. Halabi, C.D. Sigmund, and et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus J Virol 81 2007 813 821
39. C.T. Tseng, C. Huang, P. Newman, N. Wang, K. Narayanan, D.M. Watts, S. Makino, M.M. Packard, S.R. Zaki, T.S. Chan, and et al. Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor J Virol 81 2007 1162 1173
40. C.W. Day, R. Baric, S.X. Cai, M. Frieman, Y. Kumaki, J.D. Morrey, D.F. Smee, and D.L. Barnard A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo Virology 395 2009 210 222
41. J. Netland, D.M. Zhao, J. Fett, C. Alvarez, E. Nieto-Torres, J.L. Enjuanes, and L.S. Perlman Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease Virology 399 2010 120 128
42. A. Roberts, D. Deming, C.D. Paddock, A. Cheng, B. Yount, L. Vogel, B.D. Herman, T. Sheahan, M. Heise, G.L. Genrich, and et al. A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice PLoS Pathog 3 2007 e5
43. M. Frieman, B. Yount, S. Agnihothram, C. Page, E. Donaldson, A. Roberts, L. Vogel, B. Woodruff, D. Scorpio, K. Subbarao, and et al. Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease J Virol 86 2012 884 897
44. A.S. Cockrell, K.M. Peck, B.L. Yount, S.S. Agnihothram, T. Scobey, N.R. Curnes, R.S. Baric, and M.T. Heise Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection J Virol 88 2014 5195 5199
45. J. Zhao, K. Li, C. Wohlford-Lenane, S.S. Agnihothram, C. Fett, J. Zhao, M.J. Gale Jr., R.S. Baric, L. Enjuanes, T. Gallagher, and et al. Rapid generation of a mouse model for Middle East respiratory syndrome Proc Natl Acad Sci U S A 111 2014 4970 4975
46. A.S. Agrawal, T. Garron, X. Tao, B.H. Peng, M. Wakamiya, T.S. Chan, R.B. Couch, and C.T. Tseng Generation of transgenic mouse model of Middle East respiratory syndrome-coronavirus infection and disease J Virol 89 2015 3659 3670
47. A. Roberts, L. Vogel, J. Guarner, N. Hayes, B. Murphy, S. Zaki, and K. Subbarao Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters J Virol 79 2005 503 511
48. E.W. Lamirande, M.L. DeDiego, A. Roberts, J.P. Jackson, E. Alvarez, T. Sheahan, W.J. Shieh, S.R. Zaki, R. Baric, L. Enjuanes, and et al. A live attenuated severe acute respiratory syndrome coronavirus is immunogenic and efficacious in golden Syrian hamsters J Virol 82 2008 7721 7724
49. A. Roberts, W.D. Thomas, J. Guarner, E.W. Lamirande, G.J. Babcock, T.C. Greenough, L. Vogel, N. Hayes, J.L. Sullivan, S. Zaki, and et al. Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters J Infect Dis 193 2006 685 692
50. E. de Wit, J. Prescott, L. Baseler, T. Bushmaker, T. Thomas, M.G. Lackemeyer, C. Martellaro, S. Milne-Price, E. Haddock, B.L. Haagmans, and et al. The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters PLoS One 8 2013 e69127
51. B.E. Martina, B.L. Haagmans, T. Kuiken, R.A. Fouchier, G.F. Rimmelzwaan, G. Van Amerongen, J.S. Peiris, W. Lim, and A.D. Osterhaus Virology: SARS virus infection of cats and ferrets Nature 425 2003 915
52. H. Weingartl, M. Czub, S. Czub, J. Neufeld, P. Marszal, J. Gren, G. Smith, S. Jones, R. Proulx, Y. Deschambault, and et al. Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets J Virol 78 2004 12672 12676
53. Y.K. Chu, G.D. Ali, F. Jia, Q. Li, D. Kelvin, R.C. Couch, K.S. Harrod, J.A. Hutt, C. Cameron, S.R. Weiss, and et al. The SARS-CoV ferret model in an infection-challenge study Virology 374 2008 151 163
54. V.S. Raj, S.L. Smits, L.B. Provacia, J.M. van den Brand, L. Wiersma, W.J. Ouwendijk, T.M. Bestebroer, M.I. Spronken, G. van Amerongen, P.J. Rottier, and et al. Adenosine deaminase acts as a natural antagonist for dipeptidyl peptidase 4-mediated entry of the Middle East respiratory syndrome coronavirus J Virol 88 2014 1834 1838
55. A.L. Gruver, L.L. Hudson, and G.D. Sempowski Immunosenescence of ageing J Pathol 211 2007 144 156
56. B.L. Haagmans, J.M.A. van den Brand, L.B. Provacia, V.S. Raj, K.J. Stittellar, S. Getu, L. de Waal, T.M. Bestebroer, G. van Amerongen, G.M.G.M. Verjans, and et al. Asymptomatic Middle East Respiratory Syndrome Coronavirus infection in rabbits J Virol 89 2015 6131 6135 10.1128/jvi.00661-15
57. L. Haynes, and S.L. Swain Why aging T cells fail: implications for vaccination Immunity 24 2006 663 666
58. D. Deming, T. Sheahan, M. Heise, B. Yount, N. Davis, A. Sims, M. Suthar, J. Harkema, A. Whitmore, R. Pickles, and et al. Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants PLoS Med 3 2006 e525
59. L. Enjuanes, M.L. Dediego, E. Alvarez, D. Deming, T. Sheahan, and R. Baric Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease Virus Res 133 2008 45 62
60. K.G. Lokugamage, N. Yoshikawa-Iwata, N. Ito, D.M. Watts, P.R. Wyde, N. Wang, P. Newman, C.T. Kent Tseng, C.J. Peters, and S. Makino Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV Vaccine 26 2008 797 808
61. R.H. See, A.N. Zakhartchouk, M. Petric, D.J. Lawrence, C.P. Mok, R.J. Hogan, T. Rowe, L.A. Zitzow, K.P. Karunakaran, M.M. Hitt, and et al. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus J Gen Virol 87 2006 641 650
62. M. Spruth, O. Kistner, H. Savidis-Dacho, E. Hitter, B. Crowe, M. Gerencer, P. Bruhl, L. Grillberger, M. Reiter, C. Tauer, and et al. A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses Vaccine 24 2006 652 661
63. F. Yasui, C. Kai, M. Kitabatake, S. Inoue, M. Yoneda, S. Yokochi, R. Kase, S. Sekiguchi, K. Morita, T. Hishima, and et al. Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV J Immunol 181 2008 6337 6348
64. Z. Zhou, P. Post, R. Chubet, K. Holtz, C. McPherson, M. Petric, and M. Cox A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice Vaccine 24 2006 3624 3631
65. C.T. Tseng, E. Sbrana, N. Iwata-Yoshikawa, P.C. Newman, T. Garron, R.L. Atmar, C.J. Peters, and R.B. Couch Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus PLoS One 7 2012 e35421
66. H. Vennema, R.J. de Groot, D.A. Harbour, M. Dalderup, T. Gruffydd-Jones, M.C. Horzinek, and W.J. Spaan Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization J Virol 64 1990 1407 1409